Clinical trial Recruiting at 1 site Interventional Ages 19 to 45 Women only

Effects of medications on uterine contractions during cesarean delivery in diabetic patients

Official title: Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study

Run by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · NCT06285396 · Data updated 2026-11-12

This study is testing how certain medications for low blood pressure during cesarean deliveries affect uterine contractions in women with Type II and gestational diabetes.

More Postpartum Hemorrhage trials

Quick facts

Study typeInterventional
Ages19 Years to 45 Years
SexWomen only
Enrollment96 (estimated)
SponsorSamuel Lunenfeld Research Institute, Mount Sinai Hospital
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedMarch 18, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedApril 6, 2026
Trial IDNCT06285396 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include pregnant individuals aged 19-45 with Type II or gestational diabetes, scheduled for elective cesarean delivery under spinal anesthesia.

Probably not a fit

Patients who are in labor, require general anesthesia, or have had previous uterine surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how medications used to treat low blood pressure during cesarean deliveries affect the contractility of uterine muscle tissue in patients with Type II and gestational diabetes. It focuses on the impact of vasopressors like ephedrine, phenylephrine, and norepinephrine on myometrial function, as inadequate contractions can lead to postpartum hemorrhage, particularly in diabetic women. The research aims to provide insights into the relationship between these medications and uterine health during a critical time for mothers undergoing elective cesarean sections.

Why it matters

Potential benefit: If successful, this study could lead to improved management of uterine contractility and reduced risk of postpartum hemorrhage in diabetic patients during cesarean deliveries.

How similar studies have gone: While the specific approach of this study may be novel, there is existing literature on the effects of vasopressors on uterine contractility, indicating potential for meaningful insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who have given consent to participate in the study
* Patients with gestational age 37-41 weeks
* Patients previously diagnosed with either Type II or Gestational diabetes. For the healthy control group, no previous diagnosis is required for inclusion
* Patients of 19-45 years
* Patients of normal BMI (18-30 BMI) for the healthy control group only
* Baby is registered as normal weight for size for the healthy control group only
* Non-laboring patients, not exposed to exogenous oxytocin
* Patients requiring elective primary or first repeat caesarean delivery
* Patients undergoing caesarean delivery under spinal anesthesia

Exclusion Criteria:

* Patients who refuse to give written informed consent
* Patients who require general anesthesia
* Patients in labor and those receiving oxytocin for induction of labor
* Emergency caesarean delivery in labor
* Patients who have had previous uterine surgery involving myometrial dissection or \>1 previous caesarean delivery
* Patients with risk factors for PPH such as those with polyhydramnios, preeclampsia, multiple gestation, morbid obesity, macrosomia (large for size baby), and previous history of PPH. However, for diabetic group, those with morbid obesity and macrosomia will not be excluded as these conditions are almost always associated with diabetes.
* For the healthy control group only, a BMI \>30 or \<18
* Maternal age \>45

Where it's running

  • Mount Sinai Hospital
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.